Search Results - "Ikdahl, Tone"
-
1
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
Published in Journal of clinical oncology (20-05-2012)“…The NORDIC-VII multicenter phase III trial investigated the efficacy of cetuximab when added to bolus fluorouracil/folinic acid and oxaliplatin (Nordic FLOX),…”
Get full text
Journal Article -
2
Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity
Published in Journal of clinical oncology (10-12-2013)“…Gemcitabine requires transporter proteins to cross cell membranes. Low expression of human equilibrative nucleoside transporter-1 (hENT1) may result in…”
Get full text
Journal Article -
3
Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing
Published in PloS one (17-04-2012)“…We present the results of a global study of dysregulated miRNAs in paired samples of normal mucosa and tumor from eight patients with colorectal cancer…”
Get full text
Journal Article -
4
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
Published in Oncotarget (15-11-2016)“…The aim was to explore the prognostic significance of IL-6 and markers of systemic inflammatory response (SIR), in particular C-reactive protein (CRP), in…”
Get full text
Journal Article -
5
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
Published in Oncotarget (05-07-2016)“…Perivascular cells (PC) were recently implied as regulators of metastasis and immune cell activity. Perivascular heterogeneity in clinical samples, and…”
Get full text
Journal Article -
6
Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
Published in BMC cancer (20-11-2012)“…Abstract Background Recent studies have reported associations between a variant allele in a let-7 microRNA complementary site (LCS6) within the 3 ′…”
Get full text
Journal Article -
7
The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
Published in BMC cancer (10-02-2011)“…Compromised epithelial barriers are found in dysplastic tissue of the gastrointestinal tract. Claudins are transmembrane proteins important for tight…”
Get full text
Journal Article -
8
Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
Published in BMC research notes (15-06-2017)“…Given the risk of developing acute and long-term adverse effects in patients receiving cisplatin-based chemotherapy for testicular cancer (TC), risk-reducing…”
Get full text
Journal Article -
9
Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study
Published in PloS one (03-02-2014)“…We aim to test the hypothesis that high plasma YKL-40 is associated with short progression-free survival (PFS) and overall survival (OS) in patients with…”
Get full text
Journal Article -
10
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
Published in BMC cancer (12-10-2007)“…It has recently been shown that NDRG2 mRNA is down-regulated or undetectable in several human cancers and cancer cell-lines. Although the function of NDRG2 is…”
Get full text
Journal Article -
11
TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer
Published in Oncotarget (13-09-2016)“…It is now widely accepted that therapeutic antibodies targeting epidermal growth factor receptor (EGFR) can have efficacy in KRAS wild-type advanced colorectal…”
Get full text
Journal Article -
12
TP53mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Published in Breast cancer research : BCR (15-05-2007)“…Abstract Introduction Gene expression profiling of breast carcinomas has increased our understanding of the heterogeneous biology of this disease and promises…”
Get full text
Journal Article -
13
Comparing Two Classifications of Cancer Cachexia and Their Association with Survival in Patients with Unresected Pancreatic Cancer
Published in Nutrition and cancer (03-04-2015)“…There is no universally accepted definition of cancer cachexia. Two classifications have been proposed; the 3-factor classification requiring ≥2 of 3 factors;…”
Get full text
Journal Article -
14
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Published in Breast cancer research : BCR (01-01-2007)“…Gene expression profiling of breast carcinomas has increased our understanding of the heterogeneous biology of this disease and promises to impact clinical…”
Get full text
Journal Article -
15
The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma
Published in Cancer research (Chicago, Ill.) (01-09-2016)“…Despite advances in diagnostics, less than 5% of patients with periampullary tumors experience an overall survival of five years or more. Periampullary tumors…”
Get full text
Journal Article -
16
Screening for germ line TP53 mutations in breast cancer patients
Published in Cancer research (Chicago, Ill.) (01-06-1992)“…The constant denaturant gel electrophoresis technique was used to screen for TP53 germ line mutations in 237 women with breast carcinoma (167 unselected…”
Get full text
Journal Article -
17
FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab
Published in BMC cancer (19-05-2014)“…Polymorphisms of genes encoding the Fcy receptors (Fc fragment of IgG receptor 2A (FCGR2A) and 3A (FCGR3A)), which influence their affinity for the Fc…”
Get full text
Journal Article -
18
Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
Published in BMC cancer (20-11-2012)“…Recent studies have reported associations between a variant allele in a let-7 microRNA complementary site (LCS6) within the 3'untranslated region (3'UTR) of…”
Get full text
Journal Article -
19
C-reactive protein and interleukin-6 as markers of systemic inflammatory response and as prognostic factors for metastatic colorectal cancer. Data from the randomized phase III NORDIC-VII study
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
20
Screening for ESR mutations in breast and ovarian cancer patients
Published in Human mutation (1997)“…In the present study, leukocyte DNA from 143 patients with familial clustering of breast and/or ovarian cancer and tumour DNA from 96 breast carcinomas were…”
Get full text
Journal Article